Skip to content
Quebec News Tribune – Lifestyle
Author:
Adaptive Biotechnologies
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
May 29, 2026
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
May 21, 2026
Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
May 7, 2026
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026
April 15, 2026